Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meletios A Dimopoulos

Showing results (201-210 of 740) with videos related to

Pageof 74
Sort By:
Hemasphere|July 11, 2020
The Emerging Role of Convalescent Plasma in the Treatment of COVID-19Theodora Psaltopoulou, Theodoros N Sergentanis, Vasiliki Pappa, et al.
Oncotarget|May 1, 2018
Molecular responses to therapeutic proteasome inhibitors in multiple myeloma patients are donor-, cell type- and drug-dependentEleni-Dimitra Papanagnou, Evangelos Terpos, Efstathios Kastritis, et al.
Thrombosis and Haemostasis|March 12, 2009
Expression and prognostic significance of kallikrein-related peptidase 8 protein levels in advanced ovarian cancer by using automated quantitative analysisPanteleimon Kountourakis, Amanda Psyrri, Andreas Scorilas, et al.
Annals of Hematology|July 30, 2024
TEMPI syndrome: difficult to diagnose, "easy" to treat?Despina Fotiou, Eirini Solia, Foteini Theodorakakou, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|May 8, 2025
A prospective study of small fiber neuropathy in AL amyloidosisChrysanthi Bountziouka, Despina Fotiou, Foteini Theodorakakou, et al.
International Journal of Molecular Sciences|August 2, 2013
Angiogenesis-related pathways in the pathogenesis of ovarian cancerNikos G Gavalas, Michalis Liontos, Sofia-Paraskevi Trachana, et al.
Urology|January 31, 2004
Combination of LHRH analog with somatostatin analog and dexamethasone versus chemotherapy in hormone-refractory prostate cancer: a randomized phase II studyMeletios A Dimopoulos, Christos Kiamouris, Dimitra Gika, et al.
Gynecologic Oncology|January 31, 2004
Second-line chemotherapy with gemcitabine and carboplatin in paclitaxel-pretreated, platinum-sensitive ovarian cancer patients. A Hellenic Cooperative Oncology Group StudyChristos A Papadimitriou, George Fountzilas, Gerassimos Aravantinos, et al.
Cancers|July 26, 2020
Ex Vivo Models Simulating the Bone Marrow Environment and Predicting Response to Therapy in Multiple MyelomaKonstantinos Papadimitriou, Ioannis V Kostopoulos, Anastasia Tsopanidou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 21, 2010
Bortezomib with or without dexamethasone in primary systemic (light chain) amyloidosisEfstathios Kastritis, Ashutosh D Wechalekar, Meletios A Dimopoulos, et al.
Pageof 74

Showing results (201-210 of 740) with videos related to

Sort By:
Pageof 74
Hemasphere|July 11, 2020
The Emerging Role of Convalescent Plasma in the Treatment of COVID-19Theodora Psaltopoulou, Theodoros N Sergentanis, Vasiliki Pappa, et al.
Oncotarget|May 1, 2018
Molecular responses to therapeutic proteasome inhibitors in multiple myeloma patients are donor-, cell type- and drug-dependentEleni-Dimitra Papanagnou, Evangelos Terpos, Efstathios Kastritis, et al.
Thrombosis and Haemostasis|March 12, 2009
Expression and prognostic significance of kallikrein-related peptidase 8 protein levels in advanced ovarian cancer by using automated quantitative analysisPanteleimon Kountourakis, Amanda Psyrri, Andreas Scorilas, et al.
Annals of Hematology|July 30, 2024
TEMPI syndrome: difficult to diagnose, "easy" to treat?Despina Fotiou, Eirini Solia, Foteini Theodorakakou, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|May 8, 2025
A prospective study of small fiber neuropathy in AL amyloidosisChrysanthi Bountziouka, Despina Fotiou, Foteini Theodorakakou, et al.
International Journal of Molecular Sciences|August 2, 2013
Angiogenesis-related pathways in the pathogenesis of ovarian cancerNikos G Gavalas, Michalis Liontos, Sofia-Paraskevi Trachana, et al.
Urology|January 31, 2004
Combination of LHRH analog with somatostatin analog and dexamethasone versus chemotherapy in hormone-refractory prostate cancer: a randomized phase II studyMeletios A Dimopoulos, Christos Kiamouris, Dimitra Gika, et al.
Gynecologic Oncology|January 31, 2004
Second-line chemotherapy with gemcitabine and carboplatin in paclitaxel-pretreated, platinum-sensitive ovarian cancer patients. A Hellenic Cooperative Oncology Group StudyChristos A Papadimitriou, George Fountzilas, Gerassimos Aravantinos, et al.
Cancers|July 26, 2020
Ex Vivo Models Simulating the Bone Marrow Environment and Predicting Response to Therapy in Multiple MyelomaKonstantinos Papadimitriou, Ioannis V Kostopoulos, Anastasia Tsopanidou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 21, 2010
Bortezomib with or without dexamethasone in primary systemic (light chain) amyloidosisEfstathios Kastritis, Ashutosh D Wechalekar, Meletios A Dimopoulos, et al.
Pageof 74